Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Ischemic Heart Disease

  Free Subscription


22.05.2017

1 AJR Am J Roentgenol
6 Am J Cardiol
1 Am J Emerg Med
5 Am J Med
2 Angiology
2 Ann Intern Med
1 Atherosclerosis
1 BMJ
1 Catheter Cardiovasc Interv
2 Circ Cardiovasc Imaging
2 Circ Cardiovasc Interv
4 Circ Cardiovasc Qual Outcomes
2 Circ Res
5 Circulation
1 Clin Cardiol
4 Clin Chem
1 Dtsch Med Wochenschr
2 Int J Cardiol
2 J Am Coll Cardiol
1 J Clin Endocrinol Metab
1 J Electrocardiol
1 J Thorac Cardiovasc Surg
2 JAMA
1 N Engl J Med
1 Prog Cardiovasc Dis


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    AJR Am J Roentgenol

  1. CHEN J, Pu Y, Zhang Z, Yu X, et al
    Detection of Hemodynamically Significant Coronary Artery Stenosis With CT Enhancement Ratio: A Validation Study in a Porcine Model.
    AJR Am J Roentgenol. 2017 May 15:1-7. doi: 10.2214/AJR.16.16698.
    PubMed     Text format     Abstract available


    Am J Cardiol

  2. DE ROSA R, De Rosa S, Leistner D, Boeckel JN, et al
    Transcoronary Concentration Gradient of microRNA-133a and Outcome in Patients With Coronary Artery Disease.
    Am J Cardiol. 2017 Apr 12. pii: S0002-9149(17)30635.
    PubMed     Text format     Abstract available

  3. KARACSONYI J, Karmpaliotis D, Alaswad K, Jaffer FA, et al
    Impact of Calcium on Chronic Total Occlusion Percutaneous Coronary Interventions.
    Am J Cardiol. 2017 Apr 13. pii: S0002-9149(17)30634.
    PubMed     Text format     Abstract available

  4. ZOU Y, Zhao X, Hou YY, Liu T, et al
    Meta-Analysis of Effects of Voluntary Slow Breathing Exercises for Control of Heart Rate and Blood Pressure in Patients With Cardiovascular Diseases.
    Am J Cardiol. 2017 Apr 12. pii: S0002-9149(17)30618.
    PubMed     Text format     Abstract available

  5. ALFONSO F, Perez-Vizcayno MJ, Garcia Del Blanco B, Garcia-Touchard A, et al
    Usefulness of Drug-Eluting Balloons for Bare-Metal and Drug-Eluting In-Stent Restenosis (from the RIBS IV and V Randomized Trials).
    Am J Cardiol. 2017;119:983-990.
    PubMed     Text format     Abstract available

  6. CHEUNG YY, Tai BC, Loo G, Khoo SM, et al
    Screening for Obstructive Sleep Apnea in the Assessment of Coronary Risk.
    Am J Cardiol. 2017;119:996-1002.
    PubMed     Text format     Abstract available

  7. KAHN AM, Budoff MJ, Daniels LB, Oyamada J, et al
    Usefulness of Calcium Scoring as a Screening Examination in Patients With a History of Kawasaki Disease.
    Am J Cardiol. 2017;119:967-971.
    PubMed     Text format     Abstract available


    Am J Emerg Med

  8. ZHU QY, Tai S, Tang L, Peng W, et al
    ST-segment elevation myocardial infarction could be the primary presentation of acute aortic dissection.
    Am J Emerg Med. 2017 May 11. pii: S0735-6757(17)30374.
    PubMed     Text format     Abstract available


    Am J Med

  9. SHAH R, Clare RM, Chiswell K, Jones WS, et al
    Impact of Non-Infarct-Related Artery Disease on Infarct Size and Outcomes (from the CRISP-AMI Trial).
    Am J Med. 2016;129:1307-1315.
    PubMed     Text format     Abstract available

  10. KACHUR S, Menezes AR, De Schutter A, Milani RV, et al
    Significance of Comorbid Psychological Stress and Depression on Outcomes after Cardiac Rehabilitation.
    Am J Med. 2016 Jul 29. pii: S0002-9343(16)30731.
    PubMed     Text format     Abstract available

  11. PANENI F, Luscher TF
    Cardiovascular Protection in the Treatment of Type 2 Diabetes: A Review of Clinical Trial Results Across Drug Classes.
    Am J Med. 2017 May 15. pii: S0002-9343(17)30467.
    PubMed     Text format     Abstract available

  12. STAELS B
    Cardiovascular Protection by Sodium Glucose Cotransporter 2 Inhibitors: Potential Mechanisms.
    Am J Med. 2017 May 15. pii: S0002-9343(17)30468.
    PubMed     Text format     Abstract available

  13. MISRA D, Peloquin C, Kiel DP, Neogi T, et al
    Intermittent Nitrate Use and Risk of Hip Fracture.
    Am J Med. 2017;130:229.
    PubMed     Text format     Abstract available


    Angiology

  14. FISHER MB, Messerli A, Whayne TF Jr
    Characteristics, Management, and Results of Out-of-Hospital Cardiac Arrest (OHCA) With or Without ST-Segment Elevation Myocardial Infarction (STEMI).
    Angiology. 2017 Jan 1:3319717709686. doi: 10.1177/0003319717709686.
    PubMed     Text format    

  15. ASLAN G, Afsar B, Siriopol D, Kanbay A, et al
    Cardiovascular Effects of Continuous Positive Airway Pressure Treatment in Patients With Obstructive Sleep Apnea: A Meta-Analysis.
    Angiology. 2017 Jan 1:3319717709175. doi: 10.1177/0003319717709175.
    PubMed     Text format     Abstract available


    Ann Intern Med

  16. PATEL KK, Taksler GB, Hu B, Rothberg MB, et al
    Prevalence of Elevated Cardiovascular Risks in Young Adults: A Cross-sectional Analysis of National Health and Nutrition Examination Surveys.
    Ann Intern Med. 2017 May 16. doi: 10.7326/M16-2052.
    PubMed     Text format     Abstract available


  17. Prevalence of Elevated Cardiovascular Risks in Young Adults.
    Ann Intern Med. 2017 May 16. doi: 10.7326/P17-9037.
    PubMed     Text format    


    Atherosclerosis

  18. HARRIS WS, Del Gobbo L, Tintle NL
    The Omega-3 Index and relative risk for coronary heart disease mortality: Estimation from 10 cohort studies.
    Atherosclerosis. 2017;262:51-54.
    PubMed     Text format     Abstract available


    BMJ

  19. MAYOR S
    Patients with severe mental illness have greatly increased cardiovascular risk, study finds.
    BMJ. 2017;357:j2339.
    PubMed     Text format    


    Catheter Cardiovasc Interv

  20. NDREPEPA G, Colleran R, Braun S, Xhepa E, et al
    Comparative prognostic value of postprocedural creatine kinase myocardial band and high-sensitivity troponin T in patients with non-ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2017 May 13. doi: 10.1002/ccd.27105.
    PubMed     Text format     Abstract available


    Circ Cardiovasc Imaging

  21. KWON DH, Kusunose K, Obuchowski NA, Cavalcante JL, et al
    Predictors and Prognostic Impact of Progressive Ischemic Mitral Regurgitation in Patients With Advanced Ischemic Cardiomyopathy: A Multimodality Study.
    Circ Cardiovasc Imaging. 2016;9.
    PubMed     Text format     Abstract available

  22. SCHELBERT EB, Sabbah HN, Butler J, Gheorghiade M, et al
    Employing Extracellular Volume Cardiovascular Magnetic Resonance Measures of Myocardial Fibrosis to Foster Novel Therapeutics.
    Circ Cardiovasc Imaging. 2017;10.
    PubMed     Text format     Abstract available


    Circ Cardiovasc Interv

  23. KINNAIRD T, Anderson R, Ossei-Gerning N, Cockburn J, et al
    Legacy Effect of Coronary Perforation Complicating Percutaneous Coronary Intervention for Chronic Total Occlusive Disease: An Analysis of 26 807 Cases From the British Cardiovascular Intervention Society Database.
    Circ Cardiovasc Interv. 2017;10.
    PubMed     Text format     Abstract available

  24. FERRANTE G, Condorelli G, Pagnotta P, Reimers B, et al
    Dual Antiplatelet Therapy Continuation Beyond 1 Year After Drug-Eluting Stents: A Meta-Analysis of Randomized Trials.
    Circ Cardiovasc Interv. 2017;10.
    PubMed     Text format     Abstract available


    Circ Cardiovasc Qual Outcomes

  25. POKHAREL Y, Chinnakondepalli K, Vilain K, Wang K, et al
    Impact of Ezetimibe on the Rate of Cardiovascular-Related Hospitalizations and Associated Costs Among Patients With a Recent Acute Coronary Syndrome: Results From the IMPROVE-IT Trial (Improved Reduction of Outcomes: Vytorin Efficacy International Tri
    Circ Cardiovasc Qual Outcomes. 2017;10.
    PubMed     Text format     Abstract available

  26. KATZ DF, Maddox TM, Turakhia M, Gehi A, et al
    Contemporary Trends in Oral Anticoagulant Prescription in Atrial Fibrillation Patients at Low to Moderate Risk of Stroke After Guideline-Recommended Change in Use of the CHADS2 to the CHA2DS2-VASc Score for Thromboembolic Risk Assessment: Analysis Fro
    Circ Cardiovasc Qual Outcomes. 2017;10.
    PubMed     Text format     Abstract available

  27. DREYER RP, Dharmarajan K, Hsieh AF, Welsh J, et al
    Sex Differences in Trajectories of Risk After Rehospitalization for Heart Failure, Acute Myocardial Infarction, or Pneumonia.
    Circ Cardiovasc Qual Outcomes. 2017;10.
    PubMed     Text format     Abstract available

  28. ADELBORG K, Horvath-Puho E, Schmidt M, Munch T, et al
    Thirty-Year Mortality After Coronary Artery Bypass Graft Surgery: A Danish Nationwide Population-Based Cohort Study.
    Circ Cardiovasc Qual Outcomes. 2017;10:e002708.
    PubMed     Text format     Abstract available


    Circ Res

  29. NOMURA A, Won HH, Khera AV, Takeuchi F, et al
    Protein Truncating Variants at the Cholesteryl Ester Transfer Protein Gene and Risk for Coronary Heart Disease.
    Circ Res. 2017 May 15. pii: CIRCRESAHA.117.311145.
    PubMed     Text format     Abstract available

  30. ZHAN Y, Karlsson IK, Karlsson R, Tillander A, et al
    Exploring the Causal Pathway from Telomere Length to Coronary Heart Disease: A Network Mendelian Randomization Study.
    Circ Res. 2017 May 17. pii: CIRCRESAHA.116.310517.
    PubMed     Text format     Abstract available


    Circulation

  31. KARAM N, Bataille S, Marijon E, Tafflet M, et al
    Response by Karam et al to Letter Regarding Article, "Identifying Patients at Risk for Prehospital Sudden Cardiac Arrest at the Early Phase of Myocardial Infarction: The e-MUST Study (Evaluation en Medecine d'Urgence des Strategies Therapeutiques des
    Circulation. 2017;135:e1048-e1049.
    PubMed     Text format    

  32. RYDEN L, Mellbin L
    New Hope For People With Dysglycemia and Cardiovascular Disease Manifestations: Reduction of Acute Coronary Events With Pioglitazone.
    Circulation. 2017;135:1894-1896.
    PubMed     Text format    

  33. JOYNT KE
    Response to Outlier Status: Lessons From Public Reporting for Percutaneous Coronary Intervention.
    Circulation. 2017;135:1908-1910.
    PubMed     Text format    

  34. TUNCEZ A, Ates MS, Tezcan H
    Letter by Tuncez et al Regarding Article, "Identifying Patients at Risk for Prehospital Sudden Cardiac Arrest at the Early Phase of Myocardial Infarction: The e-MUST Study (Evaluation en Medecine d'Urgence des Strategies Therapeutiques des infarctus d
    Circulation. 2017;135:e1046-e1047.
    PubMed     Text format    

  35. DALE C, Fatemifar G, Palmer T, White J, et al
    Causal Associations of Adiposity and Body Fat Distribution with Coronary Heart Disease, Stroke Subtypes and Type 2 Diabetes: A Mendelian Randomization Analysis.
    Circulation. 2017 May 12. pii: CIRCULATIONAHA.116.026560.
    PubMed     Text format     Abstract available


    Clin Cardiol

  36. BAVRY AA, Elgendy IY, Elbez Y, Mahmoud AN, et al
    Aspirin and the risk of cardiovascular events in atherosclerosis patients with and without prior ischemic events.
    Clin Cardiol. 2017 May 18. doi: 10.1002/clc.22724.
    PubMed     Text format     Abstract available


    Clin Chem

  37. DUPREZ DA, Gross MD, Sanchez OA, Kizer JR, et al
    Collagen Turnover Markers in Relation to Future Cardiovascular and Noncardiovascular Disease: The Multi-Ethnic Study of Atherosclerosis.
    Clin Chem. 2017 May 17. pii: clinchem.2016.270520.
    PubMed     Text format     Abstract available

  38. EGGERS KM
    Serial Measurement of Biomarkers after Acute Coronary Syndrome: Which One to Choose?
    Clin Chem. 2017 May 17. pii: clinchem.2017.273789.
    PubMed     Text format    

  39. WILDI K, Cullen L, Twerenbold R, Greenslade JH, et al
    Direct Comparison of 2 Rule-Out Strategies for Acute Myocardial Infarction: 2-h Accelerated Diagnostic Protocol vs 2-h Algorithm.
    Clin Chem. 2017 May 17. pii: clinchem.2016.268359.
    PubMed     Text format     Abstract available

  40. CHAN M, Neely ML, Roe MT, Goodman SG, et al
    Temporal Biomarker Profiling Reveals Longitudinal Changes in Risk of Death or Myocardial Infarction in Non-ST-Segment Elevation Acute Coronary Syndrome.
    Clin Chem. 2017 May 17. pii: clinchem.2016.265272.
    PubMed     Text format     Abstract available


    Dtsch Med Wochenschr

  41. LAUBNER K, Seufert J
    [Cardiovascular Effects of Antidiabetic Therapies].
    Dtsch Med Wochenschr. 2017;142:737-745.
    PubMed     Text format     Abstract available


    Int J Cardiol

  42. REINDL M, Reinstadler SJ, Feistritzer HJ, Niess L, et al
    Persistent T-wave inversion predicts myocardial damage after ST-elevation myocardial infarction.
    Int J Cardiol. 2017 May 5. pii: S0167-5273(16)34933.
    PubMed     Text format     Abstract available

  43. SERBAN RC, Hadadi L, Sus I, Lakatos EK, et al
    Impact of chronic obstructive pulmonary disease on in-hospital morbidity and mortality in patients with ST-segment elevation myocardial infarction treated by primary percutaneous coronary intervention.
    Int J Cardiol. 2017 May 11. pii: S0167-5273(17)31197.
    PubMed     Text format     Abstract available


    J Am Coll Cardiol

  44. BIONDI-ZOCCAI G, Marullo AGM, Peruzzi M, Palmerini T, et al
    Last Nail in the Coffin for Propensity Scores in Observational Cardiovascular Studies?
    J Am Coll Cardiol. 2017;69:2575-2576.
    PubMed     Text format    

  45. ELZE MC, Gregson J, Baber U, Williamson E, et al
    Reply: Last Nail in the Coffin for Propensity Scores in Observational Cardiovascular Studies?
    J Am Coll Cardiol. 2017;69:2576-2577.
    PubMed     Text format    


    J Clin Endocrinol Metab

  46. CHAKER L, Korevaar TIM, Rizopoulos D, Collet TH, et al
    Defining optimal health range for thyroid function based on the risk of cardiovascular disease.
    J Clin Endocrinol Metab. 2017 May 17. doi: 10.1210/jc.2017-00410.
    PubMed     Text format     Abstract available


    J Electrocardiol

  47. ZHANG ZM, Rautaharju PM, Prineas RJ, Tereshchenko L, et al
    Electrocardiographic QRS-T angle and the risk of incident silent myocardial infarction in the Atherosclerosis Risk in Communities study.
    J Electrocardiol. 2017 May 4. pii: S0022-0736(17)30127.
    PubMed     Text format     Abstract available


    J Thorac Cardiovasc Surg

  48. HUEBNER M, Wolkewitz M, Enriquez-Sarano M, Schumacher M, et al
    Competing risks need to be considered in survival analysis models for cardiovascular outcomes.
    J Thorac Cardiovasc Surg. 2017;153:1427-1431.
    PubMed     Text format    


    JAMA

  49. ROTH GA, Dwyer-Lindgren L, Bertozzi-Villa A, Stubbs RW, et al
    Trends and Patterns of Geographic Variation in Cardiovascular Mortality Among US Counties, 1980-2014.
    JAMA. 2017;317:1976-1992.
    PubMed     Text format     Abstract available

  50. MENSAH GA, Goff DC, Gibbons GH
    Cardiovascular Mortality Differences-Place Matters.
    JAMA. 2017;317:1955-1957.
    PubMed     Text format    


    N Engl J Med

  51. LINCOFF AM, Nicholls SJ, Riesmeyer JS, Barter PJ, et al
    Evacetrapib and Cardiovascular Outcomes in High-Risk Vascular Disease.
    N Engl J Med. 2017;376:1933-1942.
    PubMed     Text format     Abstract available


    Prog Cardiovasc Dis

  52. OKTAY AA, Lavie CJ, Kokkinos PF, Parto P, et al
    The Interaction of Cardiorespiratory Fitness with Obesity and the Obesity Paradox in Cardiovascular Disease.
    Prog Cardiovasc Dis. 2017 May 12. pii: S0033-0620(17)30064.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Ischemic Heart Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: